Edition:
United States

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

717.40DKK
22 Mar 2019
Change (% chg)

kr.1.40 (+0.20%)
Prev Close
kr.716.00
Open
kr.720.00
Day's High
kr.724.00
Day's Low
kr.713.00
Volume
176,902
Avg. Vol
257,501
52-wk High
kr.724.00
52-wk Low
kr.496.00

Latest Key Developments (Source: Significant Developments)

Coloplast Q1 EBIT At DKK 1.30 Bln, Roughly In Line With Expectations
Tuesday, 5 Feb 2019 06:00am EST 

Feb 5 (Reuters) - Coloplast A/S ::REG-ANNOUNCEMENT NO. 1/2019 – INTERIM FINANCIAL REPORT, Q1 2018/19.REG-ANNOUNCEMENT NO. 1/2019 – INTERIM FINANCIAL REPORT, Q1 2018/19.DELIVERED 8% ORGANIC GROWTH IN Q1.Q1 PRETAX PROFIT DKK 1.29 BILLION (REUTERS POLL DKK 1.30 BILLION).Q1 REVENUE DKK 4.32 BILLION (REUTERS POLL DKK 4.32 BILLION).Q1 EBIT DKK 1.30 BILLION (REUTERS POLL DKK 1.31 BILLION).OUTLOOK 2018/19 WE CONTINUE TO EXPECT ORGANIC REVENUE GROWTH OF ABOUT 8 PERCENT AT CONSTANT EXCHANGE RATES AND A REPORTED GROWTH IN DKK OF 8-9%.OUTLOOK 2018/19 CONTINUE TO EXPECT AN EBIT MARGIN OF 30-31% AT CONSTANT EXCHANGE RATES.OUTLOOK 2018/19 REPORTED EBIT MARGIN OF ABOUT 31% IN DKK.OUTLOOK 2018/19 CAPITAL EXPENDITURE IS STILL EXPECTED TO BE DKK ABOUT 750M, AND WE CONTINUE TO EXPECT EFFECTIVE TAX RATE TO BE ABOUT 23%.  Full Article

Coloplast Q3 EBIT DKK 1.27 Billion, Below Expectations
Wednesday, 8 Aug 2018 05:59am EDT 

Aug 8 (Reuters) - Coloplast A/S ::REG-ANNOUNCEMENT NO. 5/2018 - INTERIM FINANCIAL REPORT, 9M 2017/18.DELIVERED 8% ORGANIC REVENUE GROWTH IN Q3 OF 2017/18 FINANCIAL YEAR.Q3 RESTRUCTURING COSTS AMOUNTED TO DKK 21M COMPARED WITH DKK 3M LAST YEAR,.SAYS WE NOW EXPECT ORGANIC REVENUE GROWTH OF ABOUT 8%, UP FROM PREVIOUSLY 7-8%.Q3 REVENUE DKK 4.23 BILLION (REUTERS POLL DKK 4.25 BILLION).CAPITAL EXPENDITURE IS STILL EXPECTED TO BE AROUND DKK 700M.Q3 REVENUE DKK Q3 RESTRUCTURING COSTS AMOUNTED TO DKK 21M COMPARED WITH DKK 3M LAST YEAR BILLION (REUTERS POLL DKK 4.25 BILLION).Q3 EBIT DKK 1.27 BILLION (REUTERS POLL DKK 1.32 BILLION).EXPECTATIONS FOR LONG-TERM PRICE PRESSURES, OF ABOUT 1% IN ANNUAL PRICE PRESSURE, ARE UNCHANGED..CONTINUE TO EXPECT AN EBIT MARGIN OF 31-32% AT CONSTANT EXCHANGE RATES AND A REPORTED EBIT MARGIN OF AROUND 31% IN DKK.  Full Article

Coloplast Acquires SAS Lilial
Monday, 18 Dec 2017 09:28am EST 

Dec 18 (Reuters) - Coloplast ::ANNOUNCEMENT NO. 13/2017 - COLOPLAST A/S ACQUIRES SAS LILIAL.TO ACQUIRE SAS LILIAL FOR A CASH CONSIDERATION OF EUR 35.5M EQUAL TO APPROX. DKK 264M ON A CASH AND DEBT-FREE BASIS​.‍TRANSACTION IS SUBJECT TO CUSTOMARY CLOSING CONDITIONS, AND IS EXPECTED TO CLOSE BEFORE YEAR-END 2017​.‍ACQUISITION WILL, IF COMPLETED, LEAD TO A REVISED FINANCIAL GUIDANCE FOR FINANCIAL YEAR 2017/18​.‍LILIAL IS EXPECTED TO RECORD SALES OF APPROX. EUR 33M OR APPROX. DKK 246M FOR FULL-YEAR 2017​.  Full Article

Coloplast CFO Buys 18,693 Shares In Company For Dkk 5,448,261.78‍​
Monday, 11 Dec 2017 05:26am EST 

Dec 11 (Reuters) - Coloplast ::CFO BUYS 18,693 SHARES IN COMPANY FOR DKK 5,448,261.78‍​.  Full Article

Coloplast sees 2017/2018 revenue growth at lower end of long-term outlook
Thursday, 2 Nov 2017 07:09am EDT 

Nov 2 (Reuters) - COLOPLAST :Q4 REVENUE DKK 3.98‍​ BILLION (REUTERS POLL DKK 4.02 BILLION).Q4 PRETAX PROFIT DKK ‍​1.33 BILLION (REUTERS POLL DKK 1.34 BILLION).‍EXPECT ORGANIC REVENUE GROWTH OF C7% AT CONSTANT EXCHANGE RATES.Q4 EBIT DKK ‍​1.32 BILLION (REUTERS POLL DKK 1.32 BILLION).‍EXPECTS IN 2017/2018 AN EBIT MARGIN OF 31-32% AT CONSTANT EXCHANGE RATES​.‍IN 2017/2018 CAPITAL EXPENDITURE IS EXPECTED TO BE ABOUT DKK 700M AND EFFECTIVE TAX RATE IS EXPECTED TO BE ABOUT 23%​.‍RECOMMENDS TO APPROVE A YEAR-END DIVIDEND OF DKK 10.5 PER SHARE.​.‍INTENDS TO PURSUE INORGANIC GROWTH OPPORTUNITIES TO FURTHER STRENGTHEN ITS SERVICE OFFERING TO CONSUMER​.COLOPLAST - LONG-TERM ‍ORGANIC REVENUE GROWTH GUIDANCE IS MAINTAINED AT 7-9% P.A. WHERE AMBITION IS TO REACH UPPER END OF INTERVAL​.COLOPLAST - LONG-TERM, ‍EBIT MARGIN GUIDANCE REVISED FROM 50-100BP IMPROVEMENT P.A., TO EBIT MARGIN OF >30% AT CONSTANT CURRENCIES​.  Full Article